Multiple Myeloma
Multiple Myeloma is a cancer of the plasma cells, a type of white blood cell found in the bone marrow. It leads to the production of abnormal proteins that can cause various health issues, including bone pain and kidney problems.
Myeloma: [68Ga]Ga-PentixaFor PET Imaging Study
We are studying a new imaging method to see how accurately it detects myeloma at the beginning of treatment. This may help improve risk assessment and disease management for patients.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Are you currently pregnant or breastfeeding?
- Do you have any other cancers besides non-melanoma skin cancer or effectively treated cancers that have been in remission for over 5 years?
- Can you provide written consent to participate in the study?
- Do you have any physical conditions that would prevent you from lying still for 30 minutes?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
PentixaFor
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Nuclear medicine
Heverlee, Belgium
Universitair Ziekenhuis Gent
Hematology
Ledeberg, Belgium
Antwerp University Hospital
Nuclear medicine
Wilrijk, Belgium
Sponsor: University Of Antwerp
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.